Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
China Pharmacy ; (12): 2096-2100, 2019.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-817187

RESUMO

OBJECTIVE: To analyze the formulation regularity of Chinese patent medicine for knee osteoarthritis (KOA), and to provide reference for the clinical standard use of Chinese patent medicine for KOA and the research and development of new drugs. METHODS: Chinese Pharmacopoeia (2015 edition, part Ⅰ),National Drug Reimbursement List (2017 edition), National Essential Drug List (2017 edition), Chinese Materia Medica Preparation (1992 version), Compilation of National Standard for Chinese Patent Medicines (2002 edition), Handbook of Rational Application of Chinese Patent Medicines in Surgery and Orthopedics (2010 edition) were searched to collect the type and formulation of Chinese patent medicines for “KOA”, “osteoarthritis”, “Bi syndrome”, “promoting blood circulation and removing blood stasis, dispelling wind and removing dampness, tonifying liver and kidney”. Supplementary the type and formulations of Chinese patent medicines for KOA by questionaire survey of clinial experts. The types, properties, meridian tropism, frequency and combination of medicinal materials used in Chinese patent medicine formulations were counted by using TCM inheritance auxiliary platform software V 2.5. The association rules and entropy clustering method were used to analyze the formulation regularity. RESULTS: A total of 190 Chinese patent medicines were collected, involving 289 TCM. With the top 10 used frequency being Angelica sinensis (75 times), Boswellia carterii (55 times), Carthamus tinctorius (53 times), Commiphora myrrha (51 times), Achyranthes bidentata (49 times), Notopterygium incisum (47 times), Angelica pubescens (45 times), Saposhnikovia divaricata (45 times), Angelica dahurica (39 times), Ligusticum chuanxiong (39 times). Medicinal material were mainly Xinwen in properties field and mainly liver meridian and spleen meridian in meridian entry field. Top 5 frequency of medicinal material combinations were C. myrrha-B. carterii, B. carterii-A. sinensis, A. sinensis-N. incisum, A. bidentata-A. sinensis, L. chuanxiong-A. sinensis. 14 core medicinal material combinations and 7 new developed formulations were concluded. CONCLUSIONS: This study analyzed the formulation regularity of Chinese patent medicines for KOA with the help of TCM inheritance auxiliary platform software V 2.5, which can provide reference for clinical differentiation of symptoms and signs and research and development of related new medicines related to KOA.

2.
China Pharmacy ; (12): 4478-4482, 2017.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-704440

RESUMO

OBJECTIVE:To provide reference for TCM in the treatment of coronary heart disease (CHD) unstable angina and new drug research and development.METHODS:TCM inheritance auxiliary platform software was adopted to build prescription database of TCM in the treatment of CHD unstable angina.The software function of clinical collection,platform management,information management,knowledge retrieval,statistics,data analysis were adopted to analyze prescription database in respects of four properties,five tastes,channel tropism distribution,frequency statistics,rules of prescriptions and potential new prescriptions,etc.RESULTS:Through analyzing 178 prescriptions of CHD unstable angina,152 ingredients were involved.Top 3 in the list of distribution frequency of four properties were warm (617),cold (474) and mild (288).Top 3 in the list of distribution frequency of five tastes were bitter (750),sweet (732) and pungent (497).Top 3 in the list of distribution frequency of channel tropism were liver (860),heart (573) and spleen (549).A total of 40 ingredients were used more than 10 times,and top 5 were Ligusticum chuanxiong,Salvia miltiorrhiza,Astragalus membranaceus,Angelica sinensis and Carthamus tinctorious.According to the frequency of the drug combination,top 5 in descending order were L.chuanxiong-S.miltiorrhiza,L.chuanxiong-A.sinensis,L.chuanxiong-A.membranaceus,C.tinctorious-L.chuanxiong and S.miltiorrhiza-A.membranaceus.A total of 8 new prescriptions were obtained after evolution.CONCLUSIONS:Main prescriptions for CHD unstable angina included in CNKI are mild drug property,sweetness and bitterness in taste.Main selected ingredients can promote blood circulation,remove blood stasis and relieve pain,relieve restlessness and tranquilize the mind.It embodies the CHD unstable angina treatment principles of "treat both the incidental and fundamental aspects,tonification and purgation in combination".

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...